Study of Anti-telomerase T CD4 Immunity in Melanoma
NCT02838433
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Melanoma
Interventions
OTHER:
biological samples
Sponsor
Centre Hospitalier Universitaire de Besancon